Title: Senior Global Clinical Development Director
Company: AstraZeneca
Location: Sarasota, Florida, United States
Katherine Hester, MD, Senior Global Clinical Development Director at AstraZeneca, has been recognized by Marquis Who’s Who Top Executives for dedication, achievements, and leadership in Pharmaceuticals and Biotechnology.
Dr. Hester is a prominent medical doctor specializing in pharmaceuticals as AstraZeneca’s senior global clinical development director. Since 2020, she has been at the forefront, leading the development of the area mandated by the European regulatory authority, data mandate trials, and special operations. Dr. Hester’s role encompasses working with Asian countries, leading investigator meetings with approximately six nations, overseeing clinical development and more. In addition to her role at AstraZeneca, she is a consultant contracted by AbbVie Inc.
Earlier in her career, Dr. Hester was affiliated with Memorial Sloan Kettering Cancer Center, Aventis, and Merck. Her expertise spans stem cell research for anti-aging, conducting malaria trials, and studying the newly discovered Zika virus. Over the decade, Dr. Hester plans to focus more on cancer research. She also envisions returning to a vice president role in cancer research, a successful position she previously held in her late 30s.
Educated at Berlin University, Dr. Hester received a Doctor of Medicine and a Doctor of Philosophy in immunology. She also received designations in regulatory authority, which only about 250 individuals can secure annually, and certification as an ultrasound technician and emergency physician. Dr. Hester is proficient in six languages. Outside of her professional endeavors, she chairs her local Parent Teacher Association and is a member of the Neighborhood Association and Rotary International.
For more information, please visit:
Contact Dr. Hester:
